Ignite Creation Date:
2025-12-24 @ 9:46 PM
Ignite Modification Date:
2025-12-27 @ 12:31 PM
Study NCT ID:
NCT03941132
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-02-24
First Post:
2019-05-03
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Clinical Phase II/III Trial of Ustekinumab to Treat Type 1 Diabetes (UST1D2)
Sponsor:
Organization: